Leukemia

Study explores reasons for significant variations in blood cancer survival across Europe

Study explores reasons for significant variations in blood cancer survival across Europe

The EUROCARE study, the largest population-based study of survival in European blood cancer patients to date, analyzed data from 30 cancer registries, involving all patients with cancer diagnoses in 20 European countries.

New test predicts survival in patients with leukemia

New test predicts survival in patients with leukemia

Scientists have developed a test which accurately predicts the prognosis for patients with the most common form of leukemia.

US Food and Drug Administration fast-tracks novel leukemia therapy

US Food and Drug Administration fast-tracks novel leukemia therapy

An experimental immunotherapy agent was placed on the US Food and Drug Administration's fast track to market approval after overwhelmingly positive results were seen in patients with leukemia. In early trials, 89% of patients who received the personalized immunotherapy known as CTL019 saw their cancers disappear.

Leukemia gene leads to potential target for triple-negative breast cancer treatment

Leukemia gene leads to potential target for triple-negative breast cancer treatment

Scientists have discovered that a gene previously linked to leukaemia could provide an urgently needed target for the development of drugs to treat patients with 'triple negative' breast cancer.

Game changer for leukemia therapy

Game changer for leukemia therapy

By

Cancer cells decide whether to live or die after a short period of intense exposure to targeted therapy, opposing the current requirement for continuous treatment, according to a new study.

Restoring gene function reverses cancer in common childhood leukemia

Restoring gene function reverses cancer in common childhood leukemia

Researchers in Melbourne, Australia, have shown that switching off a gene called Pax5 could cause a type of leukemia, and restoring its function could cure the disease.

Nearly one-quarter of children in remission from ALL miss doses of maintenance medication

Nearly one-quarter of children in remission from ALL miss doses of maintenance medication

Children in remission from acute lymphocytic leukemia (ALL) must take 6-mercaptopurine (6MP) for 2 years to prevent disease reemergence; however, a study shows that an estimated 25% of children in remission are not taking this essential maintenance medication at least 90% of the time, tripling their relapse risk.

One cell's food is another cell's poison

By

Loss of JAK2, a protein that can promotes the growth of cancer cells, causes healthy blood stem cells to disappear while cancer cells preserve their growth potential, according to research.

Novel target identified for chemotherapy-resistant leukemia cells

By

By targeting a particular receptor, chemotherapy-resistant cancer cells can be killed in an acute form of childhood leukemia, according to new research.

Link between Down syndrome and leukemia discovered

Link between Down syndrome and leukemia discovered

By

A team of investigators has uncovered a connection between Down syndrome and a heightened risk of developing acute lymphoblastic leukemia during childhood.

New experimental drug may be game-changer for acute myeloid leukemia

By

Clinical trials for a new experimental drug, CPX-351, to treat acute myeloid leukemia are very promising, according to researchers.

Experimental drug promising for treatment-resistant leukemia

By

The experimental compound dubbed TTT-3002 has been identified as a potent means to block genetic mutations in cancer cells blamed for some forms of treatment-resistant leukemia, according to research.

More sensitive testing may better define prognosis and treatment for leukemia

By

Nearly half of patients with the most common form of adult leukemia may have a distinct pattern of genetic abnormalities that could better define their prognosis and treatment.

Chemotherapy-free treatment a possibility for leukemia/lymphoma

Chemotherapy-free treatment a possibility for leukemia/lymphoma

By

Patients with terminal forms of leukemia and lymphoma who have run out of treatment options could soon benefit from a new drug, which not only puts an end to chemotherapy and has virtually no side effects.

Experts praise CLL trial for including elderly with coexisting conditions

By

A German study of a new drug therapy for chronic lymphocytic leukemia was praised because the majority of the patients enrolled were elderly and had other, coexisting health issues.

Genetically modified T cells eradicate advanced leukemia

By

The largest clinical study ever conducted to date of patients with advanced leukemia found that 88% achieved complete remission after being treated with genetically modified versions of their own immune cells.

Promising new approach discovered to treat leukemia

Promising new approach discovered to treat leukemia

By

A group of researchers discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression.

Complete recovery from hairy cell leukemia after vemurafenib treatment

By

Vemurafenib, a BRAF inhibitor that has been approved as a treatment for advanced melanomas, has also proved successful in treating hairy cell leukemia.

Maternal coffee consumption tied to childhood leukemia

Maternal coffee consumption tied to childhood leukemia

Linear dose-response relationship for acute lymphoblastic leukemia and acute myeloid leukemia has been observed.

Cellular senescence leads to acute promyelocytic leukemia cure

By

Targeted treatments for acute promyelocytic leukemia cause a cascade of molecular events that lead to cellular senescence and recovery. This action model could be activated in other types of cancers.

Genetic development of immune system linked to leukemia

By

Scientists have discovered a genetic signature that implicates a key mechanism in the immune system as a driving force for a type of childhood leukemia.

Target of potent drug for chronic leukemia is confirmed

By

A new study helps confirm that a molecule targeted by the experimental drug ibrutinib is critical for the development of chronic lymphocytic leukemia, the most common form of adult leukemia.

High-dose cytarabine improves outcomes in acute myeloid leukemia

By

High-dose cytarabine in induction treatment improves the outcomes of adult patients with acute myeloid leukemia (AML).

Anti-CD20 antibody plus chemo aids CLL with comorbidity

Anti-CD20 antibody plus chemo aids CLL with comorbidity

For patients with previously untreated chronic lymphocytic leukemia and coexisting conditions, combining an anti-CD20 antibody with chemotherapy is associated with improved outcomes, according to a study.

Advances in cell engineering improve prognosis of haploidentical stem cell transplantation

By

Genetically engineered cell therapies may bring hope to patients for whom standard treatments have been unsuccessful, according to two separate studies presented at the 2013 ASH Annual Meeting, in New Orleans, Louisiana.

Umbilical cord blood stem cells treat leukemia and lymphoma

Umbilical cord blood stem cells treat leukemia and lymphoma

By

Growing cord blood stem cells in a laboratory before transplanting them into patients with leukemia, lymphoma, and other blood cancers significantly improves survival, according to a new study.

New drug halves risk of graft-versus-host disease

By

A new class of drugs reduced the risk of patients contracting a serious and often deadly side effect of lifesaving bone marrow transplant treatments, according to a new study from researchers.

Genetic cause of childhood leukemia uncovered

Genetic cause of childhood leukemia uncovered

By

A genetic link specific to risk for childhood leukemia has been identified for the first time, according to a new study.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs